CompoAtlas

Aminoforce 520 mg

Withdrawn from the US market on 19 July 2024 (according to the DSLD)

NewtonEverett, food supplement from the US market

Label withdrawn from the US market. Aminoforce 520 mg (NewtonEverett), a food supplement au code-barres 689076012140, is described by its US market label. If sold in France, it would be subject to 1 point of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.

Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.

Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.

If this product were sold in France

A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.

Label composition

Brand
NewtonEverett
Barcode
689076012140
Form
Capsule
One serving
1 capsule
Servings
up to 3 servings per day
Other ingredients (in English, as written)
HMPC, Rice Flour, Magnesium Stearate
Ingredient (as written, in English)CategoryPer serving
Vitamin B6Vitamin8 mg
L-GlutamineAmino acid62 mg
L-Aspartic AcidAmino acid36 mg
L-TyrosineAmino acid34 mg
L-LeucineAmino acid32 mg
L-ValineAmino acid32 mg
TaurineOther substance30 mg
L-PhenylalanineAmino acid29 mg
L-ProlineAmino acid27 mg
L-Lysine HydrochlorideAmino acid26 mg
L-IsoleucineAmino acid24 mg
L-SerineAmino acid24 mg
L-AlanineAmino acid20 mg
L-ThreonineAmino acid20 mg
L-MethionineAmino acid18 mg
L-ArginineAmino acid18 mg
BromelainEnzymenot stated
PapainEnzymenot stated
GlycineAmino acid16 mg
L-Histidine HydrochlorideAmino acid14 mg
PancreatinBlend4 mg
L-CysteineAmino acid8 mg

Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.

Other versions of this label

The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.

This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • L-Glutamine
    Read the warning, when it applies and the studies cited

    L-Glutamine

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Health Canada monograph dated 30 January 2026

  • Taurine
    Read the warning, when it applies and the studies cited

    TAURINE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Lopez Ramon et al. 2007; Seghieri et al. 2007).

    Sources cited by Health Canada (2)
    • López Ramón Y Cajal C, Ocampo Martínez R, Couceiro Naveira E, Martínez M. Amino acids in amniotic fluid in the 15th-16th weeks of gestation and preterm labor. The Journal of Maternal-Fetal & Neonatal Medicine: the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 2007;20(3):225-231.
    • Seghieri G, Tesi F, Bianchi L, Loizzo A, Saccomanni G, Ghirlanda G, Anichini R, Franconi F. Taurine in women with a history of gestational diabetes. Diabetes Research and Clinical Practice 2007;76(2):187-192. PubMed

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 30 January 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).

Photograph the packaging

Brand : NewtonEverett

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Aminoforce 520 mg : étiquette retirée du marché américain (NewtonEverett): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/689076012140-aminoforce-520-mg-newtoneverett, updated 19 July 2024.

List recorded in 2016. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line